share_log

瑞科生物-B(02179)拟参与H股全流通计划

Ruike Bio-B (02179) plans to participate in H-share full circulation plan

Zhitong Finance ·  Jun 30, 2022 20:45

Zitong Financial App News, Ruike Bio-B (02179) announced that the board of directors has approved on June 30th, 2022, to convert about 222 million domestic shares into H shares of the company.

After the completion of the full circulation of H shares, the total number of H shares of the company will be changed to about 316 million shares, accounting for 65.46% of the total share capital of the company. In the intention of this H-share full circulation application, all the 222 million shares proposed to apply for this H-share full circulation are domestic shares, and no unlisted foreign capital shares participate in this H-share full circulation application.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment